500 related articles for article (PubMed ID: 12421226)
21. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso.
Zeba MT; Sanou M; Bisseye C; Kiba A; Nagalo BM; Djigma FW; Compaoré TR; Nebié YK; Kienou K; Sagna T; Pietra V; Moret R; Simporé J
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s54-7. PubMed ID: 24599906
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
24. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
25. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study.
Garson JA; Clewley JP; Simmonds P; Zhang LQ; Mori J; Ring C; Follett EA; Dow BC; Martin S; Gunson H
Vox Sang; 1992; 62(4):218-23. PubMed ID: 1322612
[TBL] [Abstract][Full Text] [Related]
27. [Serological and molecular genetic markers of hepatitis C virus in infected donors].
Zubkova NV; Filatova EV; Zubov SV
Vopr Virusol; 2010; 55(5):34-6. PubMed ID: 21260994
[TBL] [Abstract][Full Text] [Related]
28. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
29. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
Caspari G; Gerlich WH; Beyer J; Schmitt H
Infusionsther Transfusionsmed; 1995 Aug; 22(4):208-19. PubMed ID: 7496119
[TBL] [Abstract][Full Text] [Related]
30. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
Palomäki P; Wessberg S; Tuomi K; Laitinen H
Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
[TBL] [Abstract][Full Text] [Related]
31. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
32. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
33. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.
François M; Dubois F; Brand D; Bacq Y; Guerois C; Mouchet C; Tichet J; Goudeau A; Barin F
J Clin Microbiol; 1993 May; 31(5):1189-93. PubMed ID: 7684749
[TBL] [Abstract][Full Text] [Related]
36. Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations.
Grabarczyk P; Kubicka-Russel D; Kopacz A; Liszewski G; Sulkowska E; Zwolińska P; Madaliński K; Marek M; Szabelewska M; Świątek E; Laskus T; Radkowski M
J Med Virol; 2020 Mar; 92(3):339-347. PubMed ID: 31670401
[TBL] [Abstract][Full Text] [Related]
37. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
38. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
[No Abstract] [Full Text] [Related]
39. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
